Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
amyloidosis
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, myasthenic syndrome with
antibodies to voltage-gated calcium channels
arthrogryposis multiplex
autoantibodies
autoimmune disease
autonomic dysfunction
calcium channel dysfunction
carcinoma
cerebellar degeneration
Charcot-Marie-Tooth
dermatomyositis
fasciculation
ganglionitis
Guillain Barre syndrome
impotence
klippel feil syndrome
limbic encephalitis
mononeuritis multiplex
mononeuropathy
motor neuron disease
multiple sclerosis
muscle diseases, characteristics of
muscle relaxant
muscle weakness, proximal
muscle, metabolic disorders of
muscular dystrophy
muscular dystrophy, Duchenne
muscular dystrophy, facioscapulohumeral
muscular dystrophy, limb-girdle
myasthenia gravis
myasthenia gravis, drug induced
myasthenic crisis
myasthenic syndrome
myelopathy
myelopathy, necrotizing
myopathy
myopathy, carcinomatous
myopathy, thyroid disease causing
myositis
myotonia dystrophica
neuritis, causes of
neurologic complications of, systemic disease
neuromuscular blockade
neuromuscular junction
neuromuscular junction, abnormality of
neuronopathy, sensory
neuropathy
neuropathy, diabetic
neuropathy, peripheral
poliomyelitis
polymyositis
polyneuropathy
porphyria
remote effect of cancer on the nervous system
review article
sarcoidosis
stiff man syndrome
tensilon test
tensilon test, false positive
torticollis
Werdnig-Hoffman disease
xerostomia
Showing articles 900 to 950 of 3126 << Previous Next >>

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010

MRI Criteria for MS in Patients with Clinically Isolated Syndromes
Neurol 74:427-434, Montalban,X.,et al, 2010

Clinicopath Conf, Infantile Krabbe Disease
NEJM 362:346-356, Case 3-2010, 2010

Resuscitating the Heart but Losing the Brain: Brain Atrophy in the Aftermath of Cardiac Arrest
Neurol 74:306-312, Horstmann,A.,et al, 2010

Robot-Assisted Therapy for Long-Term Upper-Limb Impairment After Stroke
NEJM 362:1772-1783, 1827, Lo,A.C., et al, 2010

Antibodies to Glutamic Acid Decarboxylase Define a Form of Limbic Encephalitis
Ann Neurol 67:470-478, Malter,M.P., et al, 2010

Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia
JAMA 303:1823-1831, Vichinsky,E.P., et al, 2010

A Comparison of MRI Criteria for Diagnosing Pediatric ADEM and MS
Neurol 74:1412-1415, 1404, Ketelslegers,I.A., et al, 2010

Evidence Report: The Efficacy and Safety of Mitoxantrone (Novantrone) in the Treatment of Multiple Sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 74:1463-1470, Marriott,J.J., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease
AJNR 31:347-354, Walhovd, K.B.,et al, 2010

Tumefactive Multiple Sclerosis
www.medlink.com, JUne, Bunyan, R.F. and Lucchinetti, C.F., 2010

Isolated Vein Thrombosis of the Posterior Fossa Presenting as Localized Cerebellar Venous Infarctions or Hemorrhages
Stroke 41:2358-2361, Ruiz-Sandoval, J.L.,et al, 2010

Trigeminal Sensory Neuropathy Associated with Systemic Sclerosis
Arq Neuropsiquiatr 67:494-495, Ribeiro, R.T.,et al, 2009

Spinal Cord Involvement in Balos Concentric Sclerosis
J Neurol Sci 279:114-117, Kreft, K.L.,et al, 2009

Cerebral Venous Sinus Thrombosis Presenting in Pregnancy and Puerperium
BMJ Case Re doi:10.1136/bcr.06.2009.2045, Dangal,G. & Thapa,L.B., 2009

A Case with Myasthenia Gravis, Brain Stem Multiple Infarcts, Fracture of Vertebrai Th6 and discal hernia to the Th7/Th8
Radiol Oncol 43:3:170-174, KuKaj,V.,et al, 2009

Tempo of Disease. In Merritts Neurology. Signs and symptoms in neurologic diagnosis: Approach to the patient
, Rowland, L.P.,et al, 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

"Cloud-like Enhancement" Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica
Ann Neuro l 66:425-428, Ito, S.,et al, 2009

Tumefactive Demyelination: An Approach to Diagnosis and Management
JNNP 84:1047-1053, Hardy, T.A. & Chataway, J., 2009

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimers Disease
AJNR 30:578-580, Brewer, J.B.,et al, 2009

Lateral Sinus Thrombosis: Complication of Minor Head Injury
Int J Pediatr Otorhinolaryngol 73:629-635, Nehme, J.,et al, 2009

Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
JAMA 302:2565-2572, 2593, Lieb,W.,et al, 2009

A Woman With Acute Myelopathy in Pregnancy: Case Outcome
BMJ 339:1372-1376, Reu�,R.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol 66:1345-1352, Moraal,B.,et al, 2009

A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy
JAMA 302:1451-1458, Rutkove,S., 2009

Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy
NEJM 361:1349-1358, Azzopardi,D.,et al, 2009

The Present Efficacy of Multiple Sclerosis Therapeutics
Neurol 73:984-990, Klawiter,E.,et al, 2009

Severe Cardiac Failure in a Patient with Multiple Sclerosis Following Low-Dose Mitoxantrone Treatment
Neurol 73:991-993, D�rr,J.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009

Pediatric Optic Neuritis: Brain MRI Abnormalities and Risk of Multiple Sclerosis
Neurol 72:881-885, Bonhomme,G.R.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009

MRI in the Diagnosis of Pediatric Multiple Sclerosis
Neurol 72:961-967, Callen,D.J.A.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Isolated Nodular Infarction
Stroke 40:487-491, Moon,I.S.,et al, 2009

Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009



Showing articles 900 to 950 of 3126 << Previous Next >>